BRGX
Bioregenx, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern. As reflected in the accompanying financial statements, for the three months ended March 31, 2026, the Company incurred a net loss of $(26,415), generated cash from operations of $26,629 and had a stockholder’s deficit of $4,533,316 as of that date. At March 31, 2026, the Company had cash on hand in the amount of $45,806. In addition, notes payable of $522,500 are in default. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Company with tickers: BRGX
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-06-26 | 245 | 0 | 245 | 100.0% |
| 2026-06-22 | 108,000 | 0 | 108,000 | 100.0% |
| 2026-06-16 | 1 | 0 | 1 | 100.0% |
| 2026-05-19 | 50,000 | 0 | 50,000 | 100.0% |
| 2026-05-13 | 100 | 0 | 101 | 99.0% |
| 2026-05-08 | 5 | 0 | 37,005 | 0.0% |
| 2026-04-27 | 11 | 0 | 543 | 2.0% |
| 2026-04-23 | 2 | 0 | 10,002 | 0.0% |
| 2026-04-21 | 3,606 | 0 | 22,400 | 16.1% |
| 2026-04-20 | 35,300 | 0 | 35,300 | 100.0% |
| 2026-04-15 | 4,000 | 0 | 4,000 | 100.0% |
Showing 1–11 of 11 days